Business
Cannabics Pharmaceuticals Inc. Announces New Access of Cannabics Oil Capsules for Patients With Medical Cannabis License in Israel
Cannabics Pharmaceuticals Inc. Announces New Access of Cannabics Oil Capsules for Patients With Medical Cannabis License in Israel.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Inc. Announces New Access of Cannabics Oil Capsules for Patients With Medical Cannabis License in Israel\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals Inc. Announces New Access of Cannabics Oil Capsules for Patients With Medical Cannabis License in Israel\nPR Newswire\nBETHESDA, Md., Sept. 8, 2015\n\n\n\nBETHESDA, Md., Sept. 8, 2015 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that Israeli patients with a medical cannabis license will now have access to Cannabics Pharmaceutical's cannabis oil Capsules. \n\nCannabics Pharmaceuticals executed an IP Licensing and Collaboration Agreement in Israel with Bazelet Pharma for the distribution of the Company's medical cannabis capsules in Israel through approved medical cannabis growers and in strict compliance with all laws and regulations in Israel. \n\nFrom October 1, 2015, patients in Israel with a medical cannabis license shall be entitled to receive Cannabics oil capsules. These capsules are offered in two dosages: 1. Hermon-SR 10mg THC   2. Gilboa-SR 9.5mg THC, 0.5mg CBD.\n\n\"In recent years, Israel has become a superpower in the field of medical cannabis and we are excited about the opportunity to collaborate with the finest cannabis growers in Israel,\" said Dr. Eyal Ballan, Chief Scientist of Cannabics.\n\nLast month Cannabics Pharmaceuticals announced that WanaCapsXR  capsules are sold in every region of Colorado. WanaCaps XR is the result of a partnership between Wana Brands from Boulder, Colorado and Cannabics Pharmaceuticals. The two companies decided to expand into more key medical marijuana markets, including Oregon, New York, Washington, Nevada and California.\n\nSince 2012, Cannabics Pharmaceuticals has been developing an integrated treatment for cancer patients through a network of doctors, hospitals, universities and agronomists in Israel. From the first stage when the plant sprouts to extracting active compounds, formulation, diagnostics, administration meth...